PRIMECAP MANAGEMENT CO 13D and 13G filings for Calithera Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-10 12:22 pm Purchase | 2021-12-31 | 13G | Calithera Biosciences, Inc. CALA | PRIMECAP MANAGEMENT CO | 536,650 14.320% | 23,975 (+4.68%) | Filing |
| 2021-02-12 12:02 pm Purchase | 2009-02-28 | 13G | Calithera Biosciences, Inc. CALA | PRIMECAP MANAGEMENT CO | 512,675 14.530% | 9,600 (+1.91%) | Filing |
| 2020-10-08 7:01 pm Purchase | 2009-02-28 | 13G | Calithera Biosciences, Inc. CALA | PRIMECAP MANAGEMENT CO | 503,075 14.260% | 28,675 (+6.04%) | Filing |